Company Profiles

driven by the PitchBook Platform

Intervention Insights

Intervention Insights
2009 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$4.16M LATEST DEAL AMOUNT
$17.4M TOTAL AMOUNT RAISED
Description

Provider of cancer therapeutic information services intended to assist community oncologists. The company's cancer therapeutic information services include information on analysis of cancerous tissues and generation of a genomic picture of genes and corresponding molecular pathways, enabling oncology care team to access and consider medical evidence to support the molecular diagnostics and targeted therapeutics.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Information Services (B2C)
Other Industries
Drug Discovery
Other Healthcare Services
Primary Office
1601 Trapelo Road
Suite 178
Waltham, MA 02451
United States
+1 (617) 250-7572
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Intervention Insights’s full profile, request a free trial.

Intervention Insights Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 08-Nov-2017 $4.16M $17.4M 00.00 Completed Generating Revenue
3. Later Stage VC (Series B) 09-Jul-2014 00.00 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 18-Jul-2011 $9.7M $9.7M $28M Completed Startup
1. Early Stage VC 31-Mar-2010 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Intervention Insights Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A (new) 00,000,000 00.000000 00 00.00 00.00 00 00.00 000
To view this company’s complete Cap Table request access »

Intervention Insights Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ann Arbor SPARK Accelerator/Incubator Minority 000 0000 000000 0
Beringea PE/Buyout Minority 000 0000 000000 0
Biosciences Research and Commercialization Center Venture Capital Minority 000 0000 000000 0
Charter Capital Partners Investment Bank Minority 000 0000 000000 0
Chrysalis Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Intervention Insights Executive Team (3)

Name Title Board
Seat
Contact
Info
Russell Ingersoll Ph.D Chief Product Officer
Kevin McCurren Co-Founder
Clynt Taylor Chief Executive Officer & Board Member

Intervention Insights Board Members (11)

Name Representing Role Since Contact
Info
Charlie Crawford Chrysalis Ventures Board Observer 000 0000
Clynt Taylor Self Chief Executive Officer & Board Member 000 0000
Mark Olesnavage Hopen Life Science Ventures Board Observer 000 0000
Michael Gross Beringea Board Member 000 0000
Wright Steenrod Chrysalis Ventures Board Member 000 0000

6 Former Board Members

You’re viewing 5 of 11 board members. Get the full list »